Sleeper frameworks for Pathogen X: surveillance, risk stratification, and the effectiveness and safety of therapeutic interventions
Lancet Infect Dis
.
2024 Jul;24(7):e417-e418.
doi: 10.1016/S1473-3099(24)00352-9.
Epub 2024 Jun 3.
Authors
Simon de Lusignan
1
,
Ting Shi
2
,
Tom Fowler
3
,
Nick Andrews
4
,
Dan Todkill
5
,
Xinchun Gu
1
,
Bernardo Meza-Torres
1
,
Chris Robertson
6
,
Aziz Sheikh
7
Affiliations
1
Nuffield Department of Primary Care Health Sciences, University of Oxford Oxford, UK.
2
Usher Institute, University of Edinburgh, Edinburgh, UK.
3
UK Health Security Agency, London, UK; William Harvey Research Institute, Queen Mary University of London, London, UK.
4
Immunisation and Vaccine Preventable Diseases Department, UK Health Security Agency, London, UK.
5
Real Time Syndromic Surveillance Team, Field Services, UK Health Security Agency, Warwick Medical School, University of Warwick.
6
Public Health Epidemiology, University of Strathclyde, Glasgow, G1 1XQ, Scotland.
7
Usher Institute, University of Edinburgh, Edinburgh, UK. Electronic address: aziz.sheikh@ed.ac.uk.
PMID:
38843854
DOI:
10.1016/S1473-3099(24)00352-9
No abstract available
Publication types
Letter
MeSH terms
COVID-19* / prevention & control
Humans
Risk Assessment